The shares of Bristol-Myers Squibb Company (NYSE:BMY) traded with a loss of -0.06 points or -0.08% in the most recent session. The shares last traded at $70.9. As per the trading info, the shares saw $45.72 million in upticks and lost $35.95 million in downticks, resulting in a net money flow of $9.77 million. The up/down ratio for the day was measured at 1.27. For the week, the shares had posted 0.33%.From the block trade data available, the total upticks were valued at $19.79 million and the total downticks were valued at $6.6 million, thereby putting the up/down ratio at 3. The net money flow for the block transaction was $13.18 million.
The stock has recorded a 20-day Moving Average of 1.18% and the 50-Day Moving Average is 0.32%. The company shares have rallied 5.39% in the past 52 Weeks. On June 6, 2016 The shares registered one year high of $75.12 and one year low was seen on August 24, 2015 at $51.82. The 50-day moving average is $71.73 and the 200 day moving average is recorded at $66.94. S&P 500 has rallied 1.93% during the last 52-weeks.
Bristol-Myers Squibb Company (NYSE:BMY): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $71.16 and $70.36 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $71.50. The buying momentum continued till the end and the stock did not give up its gains. It closed at $71.25, notching a gain of 0.41% for the day. The total traded volume was 6,450,861 . The stock had closed at $70.96 on the previous day.
Currently the company Insiders own 0.24% of Bristol-Myers Squibb Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -15.67% . Institutional Investors own 74.66% of Bristol-Myers Squibb Company shares. During last six month period, the net percent change held by insiders has seen a change of -0.7%. On the companys insider trading activities, The Securities and Exchange Commission has divulged that Elicker John E, officer (SVP, Public Affairs & IR) of Bristol Myers Squibb Co, had unloaded 11,820 shares at an average price of $72.69 in a transaction dated on June 14, 2016. The total value of the transaction was worth $859,196.
Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products across the world. The Companys products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The Company manufactures its products in the United States, Puerto Rico and in six foreign countries. The Company promotes the use of its products directly to healthcare professionals and providers, such as doctors, nurse practitioners, physician assistants, pharmacists, technologists, hospitals, Pharmacy Benefit Managers (PBMs) and Managed Care Organizations (MCOs). It also provides information about the use of its products to consumers in the United States through direct-to-consumer print, radio, television, and digital advertising and promotion. In addition, the Company holds rights to F001287, which is a preclinical, small-molecule IDO1-inhibitor.